Ameriprise’s Allient ALNT Stock Holding History

Ameriprise’s Portfolio ALNT Stock Details ALNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-11,986	Closed	-$291K	–	4016
2024 Q4	$291K	Buy	+11,986	New	+$264K	﹤0.01%	3736

Other funds holding ALNT

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JIC

Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Ameriprise's ALNT Position: Q1 2025 in Review

Ameriprise sold out of Allient (ALNT) in Q1 2025, closing a stake of 11,986 shares — an estimated $291K sold.

Ameriprise first reported a position in ALNT in Q4 2024 and held it in 1 quarter. The position peaked at $291K in Q4 2024. 131 funds tracked by Wall St. Rank hold ALNT as of Q1 2025.

Ameriprise reported no remaining Allient position as of Q1 2025 after selling out during the quarter.
Ameriprise sold 11,986 Allient shares in Q1 2025, an estimated $291K.
Ameriprise first reported a position in Allient in Q4 2024 and held it in 1 quarter.
Ameriprise's Allient position peaked at $291K in Q4 2024.
131 funds tracked by Wall St. Rank held Allient as of Q1 2025.

Based on Ameriprise's 13F filing for Q1 2025, filed 14 May 2025.